Metoprolol Slavia

Metoprolol Tartrate, the active ingredient in Metoprolol Slavia, is a selective β1‑adrenergic receptor blocker presented as an oral tablet for oral administration. It is indicated for the management of hypertension, angina pectoris, myocardial infarction, heart failure, and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metoprolol Slavia as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide from its EU‑sourced manufacturing network. The company adheres to stringent quality standards and offers reliable logistics for global distribution.

Metoprolol Slavia is a beta‑blocker that acts on the cardiovascular system to control blood pressure and heart workload.

- Hypertension: lowers systemic blood pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival after an acute heart attack by limiting cardiac workload. - Heart failure: reduces ventricular remodeling and improves functional capacity. - Cardiac arrhythmias: stabilises abnormal heart rhythms by slowing conduction through the AV node.

Metoprolol Slavia may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Fatigue or tiredness. - Dizziness or light‑headedness. - Bradycardia (slow heart rate). - Cold extremities. - Headache. - Gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe bradycardia or heart block. - Marked hypotension. - Bronchospasm, especially in patients with asthma. - Acute heart failure exacerbation. - Allergic reactions such as rash or angioedema. - Depression or mood changes.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential risks. - Monitor blood pressure: ensure adequate control without excessive hypotension. - Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. - Use caution in asthma or chronic obstructive pulmonary disease: β1‑selectivity may not fully prevent bronchospasm. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension or tachycardia. - Adjust dose in renal impairment: reduced clearance may increase exposure. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol Slavia can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective beta blockers: additive bradycardia. - Calcium‑channel blockers (verapamil, diltiazem): risk of severe bradycardia and AV block. - Clonidine: abrupt withdrawal may cause hypertensive crisis. - Insulin or oral hypoglycemics: may mask hypoglycaemia symptoms. - MAO inhibitors: potential for exaggerated hypotensive response.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effect. - Diuretics: risk of excessive blood pressure reduction. - Antidepressants (SSRIs, SNRIs): possible additive effects on heart rate.